HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William H Westra Selected Research

Immunotherapy

11/2023Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.
1/2018HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William H Westra Research Topics

Disease

107Neoplasms (Cancer)
03/2024 - 03/2002
40Squamous Cell Carcinoma of Head and Neck
11/2023 - 12/2003
25Carcinoma (Carcinomatosis)
09/2023 - 05/2002
16Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 05/2002
13Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2022 - 05/2002
10Lung Neoplasms (Lung Cancer)
09/2015 - 07/2002
9Carcinogenesis
12/2017 - 05/2002
7Thyroid Neoplasms (Thyroid Cancer)
01/2023 - 03/2003
6Oropharyngeal Neoplasms
01/2020 - 07/2005
6Neoplasm Metastasis (Metastasis)
01/2015 - 07/2005
5Melanoma (Melanoma, Malignant)
06/2012 - 05/2004
4Papillary Thyroid Cancer
05/2009 - 04/2003
4Urinary Bladder Neoplasms (Bladder Cancer)
02/2008 - 09/2003
3Insulinoma
01/2023 - 11/2017
3Adenocarcinoma
10/2021 - 01/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2015 - 03/2007
3Nevus (Nevi)
03/2012 - 12/2007
3Mitochondrial Diseases (Mitochondrial Disease)
09/2010 - 06/2002
3Margins of Excision
09/2010 - 04/2004
3Infections
04/2010 - 05/2007
2Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
02/2024 - 01/2022
2Lymphatic Metastasis
10/2021 - 07/2008
2COVID-19
01/2021 - 01/2021
2Disease Progression
12/2018 - 02/2014
2Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2017 - 11/2006
2Thyroid Nodule (Nodule, Thyroid)
09/2017 - 10/2008
2Adenocarcinoma of Lung
01/2010 - 07/2002
2Prostatic Neoplasms (Prostate Cancer)
09/2005 - 04/2003
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
10/2021
1Signet Ring Cell Carcinoma
10/2021
1Neoplasms, Cystic, Mucinous, and Serous
10/2021
1Papillary Cystadenocarcinoma
10/2021
1Granuloma
06/2021
1Foreign-Body Granuloma (Granuloma, Foreign Body)
06/2021
1Extranodal Extension
01/2021
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2021
1Acinar Cell Carcinoma
01/2021
1Acquired Immunodeficiency Syndrome (AIDS)
01/2018
1Alveolar Rhabdomyosarcoma
01/2018

Drug/Important Bio-Agent (IBA)

42DNA (Deoxyribonucleic Acid)IBA
03/2024 - 05/2002
25Biomarkers (Surrogate Marker)IBA
11/2023 - 12/2003
21Proteins (Proteins, Gene)FDA Link
01/2023 - 08/2002
12RNA (Ribonucleic Acid)IBA
11/2023 - 12/2012
9Mitochondrial DNA (mtDNA)IBA
09/2010 - 06/2002
7Messenger RNA (mRNA)IBA
01/2021 - 12/2012
7NucleotidesIBA
04/2009 - 04/2003
6AdenineFDA LinkGeneric
04/2009 - 04/2003
6ThymineIBA
04/2009 - 04/2003
5Cisplatin (Platino)FDA LinkGeneric
01/2021 - 02/2003
5Telomerase (Telomerase Reverse Transcriptase)IBA
10/2011 - 05/2004
4SynaptophysinIBA
01/2023 - 11/2017
3ChromograninsIBA
01/2023 - 11/2017
3Phenobarbital (Luminal)FDA Link
12/2021 - 02/2009
3CytokinesIBA
01/2021 - 04/2005
3Parathyroid Hormone (Parathormone)IBA
07/2014 - 01/2004
3AntigensIBA
02/2011 - 08/2006
3Electron Transport Complex IV (Cytochrome c Oxidase)IBA
09/2010 - 04/2005
3Indicators and Reagents (Reagents)IBA
08/2009 - 07/2005
2Keratins (Keratin)IBA
02/2024 - 01/2022
2Immune Checkpoint InhibitorsIBA
11/2023 - 01/2018
2Formaldehyde (Formol)FDA Link
11/2023 - 05/2004
2ThyroglobulinFDA Link
01/2023 - 04/2005
2CalponinsIBA
12/2021 - 01/2019
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 07/2014
2Protein Isoforms (Isoforms)IBA
12/2018 - 09/2011
2Transcription Factors (Transcription Factor)IBA
01/2018 - 11/2017
2SmokeIBA
11/2015 - 08/2009
2Cell-Free Nucleic AcidsIBA
09/2015 - 12/2006
2MicroRNAs (MicroRNA)IBA
08/2015 - 01/2010
2Carrier Proteins (Binding Protein)IBA
04/2013 - 06/2007
2hydrogen sulfite (bisulfite)IBA
04/2013 - 02/2011
2DecitabineFDA Link
04/2013 - 11/2007
2Viral DNAIBA
02/2011 - 06/2004
2VaccinesIBA
02/2011 - 05/2010
2Oncogene Proteins (Oncogene Protein)IBA
01/2008 - 05/2007
2EnzymesIBA
03/2007 - 04/2003
1pembrolizumabIBA
11/2023
1NivolumabIBA
11/2023
1CAM 5.2 antigenIBA
01/2023
1MART-1 AntigenIBA
01/2023
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2023
1Melanins (Melanin)IBA
01/2023
1Colloids (Colloid)IBA
10/2021
1MucinsIBA
10/2021
1Dermal FillersIBA
06/2021
1Interleukin-8 (Interleukin 8)IBA
01/2021
1NucleoproteinsIBA
01/2021
1Aligeron (AS 2)IBA
01/2021

Therapy/Procedure

27Therapeutics
11/2023 - 11/2004
8Radiotherapy
11/2022 - 02/2004
5Thyroidectomy
01/2023 - 02/2003
5Neck Dissection (Radical Neck Dissection)
01/2021 - 07/2005
4Drug Therapy (Chemotherapy)
01/2014 - 04/2002
3Chemoradiotherapy
01/2021 - 07/2005
3Aftercare (After-Treatment)
01/2012 - 11/2008
2Immunotherapy
11/2023 - 01/2018
2Injections
06/2021 - 02/2003
2Induction Chemotherapy
02/2017 - 02/2008
2Lymph Node Excision (Lymph Node Dissection)
01/2004 - 10/2003
1Precision Medicine
01/2019